PROCEDURE FOR DMPC TREATMENT OF GLASSWARE AND PLASTICWARE

Techniques and experiments in molecular biology employed in the study of infectious diseases greatly rely on information obtained by studying the genetic material from pathogens or of infected individuals. It is important that the laboratory work areas are clean and free from nucleases that can degrade DNA or RNA. Aside from work areas, commonly used continue reading : PROCEDURE FOR DMPC TREATMENT OF GLASSWARE AND PLASTICWARE

UNDERSTANDING SARS-COV-2 RT-PCR TEST RESULTS

Laboratory confirmation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) is crucial in the pandemic response. To date, detection of unique viral sequences (genetic material) using nucleic acid amplification tests (NAATs) primarily through Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR), is considered by the World Health continue reading : UNDERSTANDING SARS-COV-2 RT-PCR TEST RESULTS

GUIDELINES ON THE RECOGNITION OF TRAINING PROVIDERS FOR COVID19 RELATED TRAININGS (RT-PCR TESTING, BIOSAFETY/ BIOSECURITY, FIT
TESTING, OPS AND NPS SAMPLE COLLECTION)

RATIONALEIn accordance with Department Memorandum No. 2020-0538, the Research Institute for Tropical Medicine (RITM) is authorized to designate and certify training providers capacitating licensed COVID-19 testing laboratories, including training for new techniques such as pooled testing, and providing the requisite training for laboratories securing license-to-operate as COVID-19 testing laboratories. SCOPEThis guideline shall apply to all continue reading : GUIDELINES ON THE RECOGNITION OF TRAINING PROVIDERS FOR COVID19 RELATED TRAININGS (RT-PCR TESTING, BIOSAFETY/ BIOSECURITY, FIT
TESTING, OPS AND NPS SAMPLE COLLECTION)

GUIDELINES FOR THE RITM NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (RITM-NEQAS)

RATIONALE As a DOH-designated National Reference Laboratory for infectious diseases (DO 2020-0820), RITM is mandated to provide EQA to laboratories in the country for bacteriology (including mycobacteriology), parasitology, transfusion-transmissible infections, and SARS-CoV-2. An External Quality Assessment Scheme (EQAS) evaluates the performance of participating laboratories by assessing the integrity of the entire testing process from sample continue reading : GUIDELINES FOR THE RITM NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (RITM-NEQAS)

Biosafety Guidelines for laboratories handling and testing respiratory specimen for laboratory diagnosis of COVID-19 using Rapid Antigen Detection Kit

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is a virus responsible for the 2019 Coronavirus disease (COVID-19). It is a disease-causing human pathogen. It is vital that laboratories performing SARS-CoV-2 diagnostic tests and related laboratory procedures, including point-of-care testing, adhere to the standard biosafety practices and procedures and comply to the national guidelines as part of laboratory continue reading : Biosafety Guidelines for laboratories handling and testing respiratory specimen for laboratory diagnosis of COVID-19 using Rapid Antigen Detection Kit

RITM BRMO COVID-19 Specimen Storage and Disposition Guidelines

COVID-19 Testing Laboratories must determine the disposition of specimen used for laboratory diagnosis of SARS-CoV-2. Disposition pertains to the destination of specimen and information including its storage, transfer, destruction, and disposal after the desired laboratory procedures and/or examination has been performed.

Biosafety Guidelines for COVID 19 Testing Laboratories Using GeneXperts

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-COV-2) is a virus responsible for the 2019 Coronavirus disease (COVID-19). It is a disease-causing human pathogen. It is important that laboratories performing SARS-COV-2 diagnostic tests and related laboratory procedures adhere to the standard biosafety practices and procedures in compliance to the national guidelines as part of laboratory biorisk management. A continue reading : Biosafety Guidelines for COVID 19 Testing Laboratories Using GeneXperts

TROUBLESHOOTING GUIDE FOR REAL-TIME PCR RUNS FOR SARS-CoV-2 DETECTION

A well-designed and -optimized polymerase chain reaction (PCR)-based assay has the potential to be a highly sensitive and highly specific nucleic acid target detection method, relative to other diagnostic methods. However, even good PCR assays have limitations as there are many factors which have to be controlled to ensure the success of a PCR run. continue reading : TROUBLESHOOTING GUIDE FOR REAL-TIME PCR RUNS FOR SARS-CoV-2 DETECTION